INTRODUCTION AND OBJECTIVES: FTO was the first GWAS identified gene which was associated with obesity, considering the interaction between obesity and renal cell carcinoma(RCC), the biological role of FTO in RCC is of great interest.
INTRODUCTION AND OBJECTIVES: VHL is characterized as a tumour suppressor, being suppressed in up to 90% of clear cell Renal Cell Carcinomas (ccRCC). Canonically, VHL binds to and mediates degradation of hypoxia inducible factors (HIF). However, VHL has been discovered to bind other proteins, like p53, thereby altering the cell in more ways than just HIF degradation. Furthermore, there are conflicting reports on the impact of VHL on cancer proliferation and apoptosis, which can be regulated by p53 target genes, like p21 and PUMA. We hypothesize that VHL inhibits p53 activation paradoxically leading to increased proliferation and reduced apoptosis in cancer cells.
METHODS: VHL-deficient cells were transiently (adenoviral) or stably (lentiviral) transduced with VHL. We generated VHL knockout cells using CRISPR/Cas9 genome editing technology. HIF overexpression was achieved using hypoxia or a non-degradable HIFexpressing adenovirus. Immunodeficient nude mice were injected with tumor cells bilaterally (left, -VHL; right, +VHL) and treated with weekly injections of doxorubicin (2mg/kg, IP). Co-immunoprecipitations, immunoblots, confocal imaging and siRNA transfections were performed using standard techniques.
RESULTS: Transient and stable VHL overexpression robustly decreased, while knockout of VHL increased p21/PUMA mRNA and protein levels. VHL-deficient cells lacking HIF (via siRNA) had unaltered p21. Conversely, VHL and non-degradable HIF mutant co-expressing cells exhibited low p21 levels compared to VHL-deficient cells. Taken together, these data suggest that VHL-mediated p53 regulation is independent of HIF. VHL over-expression significantly attenuated induction of apoptosis in doxorubicin (p53 activator) treated cells. Prior to treatment, VHL-deficient tumors grew larger than VHL expressing tumors. However, doxorubicin resulted in a more significant reduction in tumor size in VHL-deficient tumors.
CONCLUSIONS: These results suggest an inhibitory interaction between VHL and p53, in which VHL mediates reduces p53 target gene expression. Furthermore, the attenuation of doxorubicin treatment in VHL-expressing cancer cells suggests that this chemotherapy may be more effective against VHL-deficient tumors or in combination with a VHL inhibitor. This work suggests that through a previously undescribed mechanism, a known tumor suppressor may paradoxically be capable of potentiating cancer growth and apoptosis resistance. has been reported to promote tumor growth and invasion in several cancers and the expression of miR-224 was significantly higher in clear cell RCC (CCRCC) compared with normal kidney. However, the function of miR-224 in CCRCC remains unclear. In this study, we focused on the role of miR-224 in CCRCC as well as examination of miR-224 expression pattern in tissues and identified candidate tumor suppression gene, eyes absent 4(EYA4) as target gene of miR-224.
Source of
METHODS: We investigated the expression level of miR-224 in 118 CCRCC patients who underwent surgical treatment at our institution and analyzed the relationship between the expression of miR-224 and clinic-pathological parameters. Then we did functional analysis of miR-224 using RCC cells and normal cell (RPTEC). EYA4 was identified as target gene of miRNA-224 using computer algorithm. The direct interaction analysis between miR-224 and EYA4 was also performed. We investigated functional analysis of EYA4.
RESULTS: The expression level of miR-224 was higher in CCRCC tissues compared to matched normal kidney tissues. We divided 118 patients to two groups. A high miR-224 expression was associated with worse prognosis in CCRCC patients (Fig 1) . Higher miR-224 expression was only risk factor related to progression, cancerspecific death, and overall survival. After knocking down of miR-224 in RCC cells, cell viability, invasion, migration ability were significantly decreased, whereas significantly increase of cell apoptosis in cell lines. There was an inverse correlation between miR-224 and EYA4 protein expression in CCRCC patients. After overexpression of EYA4, the cell viability and invasion were significantly inhibited in EYA4-transfected cells. Percentages of apoptotic cells were significantly increased in EYA4 transfected RCC cells compared with empty vector.
CONCLUSIONS: This is the first report to demonstrate that miR-224 expression is significantly increased in CCRCC as an Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e795
